Cencora (COR) Free Cash Flow Growth (1y) (2010 - 2026)
Cencora (COR) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -56.19% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -63.60% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -39.98% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -2,133.33% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -50.97% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 45.60% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 164.21% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -442.36% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.60% |
| Dec 31, 2025 | 14.17% |
| Sep 30, 2025 | 252.50% |
| Jun 30, 2025 | -103.13% |
| Mar 31, 2025 | 425.08% |
| Dec 31, 2024 | -448.32% |
| Sep 30, 2024 | -50.46% |
| Jun 30, 2024 | 268.33% |
| Mar 31, 2024 | -288.21% |
| Dec 31, 2023 | 27.84% |
| Sep 30, 2023 | 66.65% |
| Jun 30, 2023 | 117.00% |
| Mar 31, 2023 | 284.61% |
| Dec 31, 2022 | -19.06% |
| Sep 30, 2022 | 17.26% |
| Jun 30, 2022 | -72.81% |
| Mar 31, 2022 | 125.35% |
| Dec 31, 2021 | -6.44% |
| Sep 30, 2021 | -28.43% |
| Jun 30, 2021 | 657.93% |